June 09, 2021
Amidst much controversy and debate, the FDA greenlighted the use of a new drug, Aduhelm (aducanumab), for treating patients with early onset Alzheimer’s. The new drug, manufactured by Biogen, is the first of its kind to be approved in 18 years, despite strong opposition from Alzheimer’s experts. Currently, more than…
